-

Spectrum Solutions Receives CE Mark Approval for its SDNA-2000 and SDNA-3000 Saliva Collection Devices used for IVD Molecular Diagnostic Testing

SALT LAKE CITY--(BUSINESS WIRE)--Spectrum Solutions, LLC today announced receiving CE Mark approval for the sale and distribution of its groundbreaking SDNA saliva collection device for IVD molecular diagnostic testing throughout Europe. The Spectrum SDNA-2000 model has been approved for integration in over the counter at-home testing kits with the SDNA-3000 model approved for prescription-only molecular diagnostic IVD testing applications.

“Receiving CE Mark approval for the SDNA-2000 and SDNA-3000 is a major milestone for our company and this offers physicians, healthcare organizations, governments, and individuals needing repeat IVD diagnostic testing an easy and pain-free option,” said Stephen Fanning, CEO of Spectrum Solutions. “At-home bio-sample self-collection means staying home when you don’t feel good and limiting exposure to other harmful illnesses for those most at risk.”

The Spectrum Solutions SDNA Saliva Collection Device was the first saliva-based diagnostic testing solution to receive the U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for COVID-19 testing in the United States.

Bio-samples collected with the SDNA saliva collection system consistently demonstrate higher levels of testing accuracy, provide the safest & most robust testing biomaterial, is able to pinpoint an infection’s lifecycle stage, and delivers over 10 days of post-collection stability with no degradation in sample efficacy. The device’s intuitive ease-of-use design was engineered to facilitate unsupervised testing sample self-collection virtually eliminating user collection errors.

ABOUT SPECTRUM SOLUTIONS AND SPECTRUM DNA

Headquartered in Salt Lake City, Utah, Spectrum Solutions and its medical device and services division, Spectrum DNA, focus their concentrated industry expertise on engineering innovative end-to-end solutions for both clinical diagnostic projects and commercial product plans. Spectrum Solutions is a single-source provider of on-site medical device development and manufacturing, custom packaging, kitting, and direct-to-consumer fulfillment. Its bio-sample collection devices, patented technologies, and dedicated services deliver measurable process optimization, unprecedented efficiency, and unmatched global scalability. For more information, please visit spectrumsolution.com/SDNA.

Contacts

Tim Rush
Springboard5
801-208-1100
tim.rush@springboard5.com

Spectrum Solutions, LLC


Release Summary
Spectrum Solutions, LLC received CE Mark approval for its SDNA saliva collection device for IVD molecular diagnostic testing throughout Europe.
Release Versions

Contacts

Tim Rush
Springboard5
801-208-1100
tim.rush@springboard5.com

More News From Spectrum Solutions, LLC

Spectrum Solutions® Releases the New SimplyPERIO™ Saliva Test Powered by SimplyTest®

SALT LAKE CITY--(BUSINESS WIRE)--Spectrum Solutions®, saliva diagnostic biotech leader, is announcing the official release of a new saliva diagnostic testing innovation, SimplyPERIO...

Spectrum Solutions Names Bill Phillips as New Chief Executive Officer

SALT LAKE CITY--(BUSINESS WIRE)--Spectrum Solutions® and its owned corporations, Alimetrix, Inc., and Microarrays, Inc., today announced the appointment of Bill Phillips as the company’s new chief executive officer, replacing Stephen J. Fanning, who successfully served as Spectrum’s CEO for over four years. Phillips was a founder of Spectrum Solutions and prior to his promotion to CEO, he served as the company’s Chief Operating Officer where he was recognized for his outstanding performance, st...

Knobbe Martens Secures Complete Victory for Spectrum Solutions in Covid-19 Testing PTAB Dispute

IRVINE, Calif.--(BUSINESS WIRE)--A team from Knobbe Martens led by Ali Razai secured a decisive, complete and unprecedented victory for Spectrum Solutions, LLC in inter partes review (IPR) challenges of five separate patents owned by Longhorn Vaccines & Diagnostics. In an Order granting Spectrum’s Motion for Sanctions, the U.S. Patent and Trademark Office’s (USPTO) Patent Trial and Appeal Board (PTAB) found that Longhorn “committed an egregious abuse of the PTAB process” during the IPR proc...
Back to Newsroom